Skip to content

An Open label, non comparative twice daily 4 week clinical efficacy and safety study of Foot care cream in the management of foot cracks

EVALUATION OF THE EFFICACY AND SAFETY OF A FOOT CARE CREAM IN THE MANAGEMENT OF FOOT CRACKS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/07/001929
Enrollment
40
Registered
2011-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Foot Care Cream (Herbal extracts, Essential oils and Vitamins): Wash and clean the feet with water then gently wipe with the towel/tissue paper and dry it into air. Apply the product to

Sponsors

Cadila Healthcare Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Age: 18 to 65 years old; (both inclusive) 2)Sex: Males and Non-pregnant, non-lactating females 3)Volunteer having visible cracks on one or both feet. 4)Volunteer is in good physical health as determined by the Investigator/physician.

Exclusion criteria

Exclusion criteria: 1)Volunteers with skin infections over feet, widespread active infected dermatitis or dermatitis on test area. 2)Volunteers with allergies to cosmetics, moisturizers agents or other body treatment products, i.e. foot cream. 3)Volunteer who are willing to continue any personal care products containing foot care properties during study. 4)Volunteers with occupation that require the feet to be dipped/soaked in water or detergent for long hours like housekeeping/washer man, etc. 5)History or presence of Diabetes. 6)History of skin cancer or treatment for any type of cancer within the last 2 years. 7)Past or present medical history of significant dermatologic diseases or conditions, such as atopy, psoriasis, eczema, atopic dermatitis, vitiligo or conditions known to alter skin appearance or physiologic response (e.g. porphyria).

Design outcomes

Primary

MeasureTime frame
1.Visual evaluation (dryness and cracking) 2.Assessment of pain over the feet 3.Self Evaluation questionnaire to evaluate the product efficacy and sensorial properties Timepoint: Baseline visit Day 01 Day 02 Day 03 Week 1 Week 2 Week 3 Week 4

Secondary

MeasureTime frame
Clinical evaluation for tolerance and subject compliance to therapyTimepoint: Baseline visit Day 01 Day 02 Day 03 Week 1 Week 2 Week 3 Week 4

Countries

India

Contacts

Public ContactDr Hema Sharma Datta

BA Research India Limited

ssethi@baresearchindia.com07966135618

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026